| 4.06 Data as of May 22 | -0.24 / -5.58%Today’s Change | 3.35 Today|||52-Week Range 5.11 | -4.92% Year-to-Date |
The 6 analysts offering 12-month price forecasts for RTI Biologics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.50. The median estimate represents a +23.15% increase from the last price of 4.06.

The current consensus among 7 polled investment analysts is to Buy stock in RTI Biologics Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




